José Antonio García-Marco

8PUBLICATIONS
70CO-AUTHORS
Natural language processingCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 17, 2024
Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study.

Pau Abrisqueta-Costa, José Antonio García-Marco, Antonio Gutiérrez

|Mar 27, 2024
Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis.

Fernando Martin-Moro, Javier Lopez-Jimenez, Jose A Garcia-Marco

|May 31, 2023
Obinutuzumab plus bendamustine for relapsed/refractory chronic lymphocytic leukemia and predictive and prognostic impact of genetic alterations: the phase II GABRIELL study.

Julio Bravo, Patricia Baltasar Tello, Esther González Garcia

|Nov 02, 2021
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò

|Jan 07, 2021
Building a network of TP53 and IGHV testing reference centers across Spain: the Red53 initiative.

Francesc Bosch, Blanca Navarro, Marta Crespo

|Jul 11, 2020
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

Lydia Scarfò, Thomas Chatzikonstantinou, Gian Matteo Rigolin

Pageof 2

Frequent Collaborators

4 joint publications

Jose-Ángel Hernández-Rivas

2 joint publications

Alberto Lopez-Garcia

2 joint publications

Carsten U Niemann

2 joint publications

Viola Maria Popov